Core Viewpoint - The credit rating agency maintains the credit rating of Yirui Technology Group Co., Ltd. at AA with a stable outlook, indicating strong financial health and operational performance in the digital X-ray detector industry [1][8]. Company Overview - Yirui Technology primarily engages in the research, production, and sales of digital X-ray detectors, and is one of the few manufacturers globally capable of mass production of amorphous silicon, IGZO, CMOS, and flexible substrate sensor technologies [9][11]. - As of March 2025, the company's total assets amounted to 91.34 billion yuan, with total liabilities at 35.81 billion yuan and equity at 47.83 billion yuan [12]. Financial Performance - The company reported total revenue of 18.31 billion yuan in 2024, with a profit of 5.07 billion yuan, reflecting a slight decline in revenue compared to the previous year [8][12]. - The gross profit margin remains high, although there was a decrease in revenue from digital X-ray detectors by 12.04% due to increased market competition and economic factors [21]. Market Position and Growth - The global digital X-ray detector market is expected to grow, driven by advancements in technology and increasing demand in the medical sector, with a projected market size of 50.3 billion USD by 2030 [16][19]. - The company has established a strong market presence in the medical and industrial sectors, with significant sales growth in new core components and comprehensive solutions [9][21]. Investment and Projects - The company issued 14.35 billion yuan in convertible bonds to fund projects related to new detector technologies and the establishment of a comprehensive innovation base [13]. - The projects are expected to enhance production capacity significantly, with an anticipated increase of 32,000 units for CMOS detectors and 2,000 units for CT detectors upon completion [13]. Industry Analysis - The digital X-ray detector industry is characterized by high technical barriers and a concentrated market, with major players including both domestic and international firms [20][21]. - The industry is poised for growth as domestic manufacturers improve their R&D capabilities, potentially leading to a shift in global production bases for X-ray core components [21].

| 证券代码：688301 | 证券简称：奕瑞科技 | 公告编号：2025-045 | | --- | --- | --- | | 转债代码：118025 | 转债简称：奕瑞转债 | | 奕瑞电子科技集团股份有限公司 股东询价转让定价情况提示性公告 股东海南合毅投资有限公司保证向奕瑞电子科技集团股份有限公司提供的 信息内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其真实性、准确 性和完整性依法承担法律责任。 重要内容提示： 根据 2025 年 6 月 23 日询价申购情况，初步确定的奕瑞电子科技集团股 份有限公司（以下简称"公司"）股东询价转让（以下简称"本次询价转让"）的 转让价格为 75.86 元/股。 受让方通过询价转让受让的股份，在受让后 6 个月内不得转让。 一、本次询价转让初步定价 （一）经向机构投资者询价，初步确定的转让价格为 75.86 元/股。 （二）参与本次询价转让报价的机构投资者共 29 家，涵盖了基金管理公司、 保险公司、证券公司、期货公司、合格境外投资者、私募基金管理人等专业机构 投资者。参与本次询价转让报价的机构投资者合计有效认购股份数量为 1,164 万 股，对应的有效认购 ...

本次债券评级：公司主体信用等级为"AA"，评级展望为"稳定"，"奕瑞 转债"的信用等级为"AA"。 | 证券代码：688301 | 证券简称：奕瑞科技 | 公告编号：2025-044 | | --- | --- | --- | | 转债代码：118025 | 转债简称：奕瑞转债 | | 奕瑞电子科技集团股份有限公司 关于"奕瑞转债"跟踪信用评级结果的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 前次债券评级：公司主体信用等级为"AA"，评级展望为"稳定"，"奕瑞 转债"的信用等级为"AA"。 1 特此公告。 根据《上市公司证券发行注册管理办法》《上海证券交易所科创板股票上市 规则》等有关规定，奕瑞电子科技集团股份有限公司（以下简称"公司"）委托 信用评级机构东方金诚国际信用评估有限公司（以下简称"东方金诚"）对公司 向不特定对象发行的可转换公司债券（以下简称"奕瑞转债"）进行了跟踪信用 评级。 公司前次主体信用等级为"AA"，评级展望为"稳定"，"奕瑞转债"的信用 等级为"AA"，评级机构为东方金诚， ...

奕瑞科技公告，根据2025年6月23日询价申购情况，初步确定的股东询价转让转让价格为75.86元/股。 受让方通过询价转让受让的股份，在受让后6个月内不得转让。参与本次询价转让报价的机构投资者共 29家，合计有效认购股份数量为1164万股，对应的有效认购倍数约为1.9倍。本次询价转让拟转让股份 已获全额认购，初步确定受让方为22家机构投资者，拟受让股份总数为612.24万股。 ...

金融界6月23日消息，上证指数低开高走，上证科创板医疗指数 (科创医疗，950255)报697.06点。 数据统计显示，上证科创板医疗指数近一个月下跌4.19%，近三个月下跌7.99%，年至今下跌3.88%。 据了解，上证科创板医疗指数从科创板中选取不超过30家医疗领域的上市公司证券作为指数样本，以反 映科创板中医疗上市公司证券的整体表现。该指数以2022年12月30日为基日，以1000.0点为基点。 从指数持仓来看，上证科创板医疗指数十大权重分别为：惠泰医疗（10.77%）、联影医疗 （10.14%）、奕瑞科技（7.2%）、爱博医疗（6.29%）、热景生物（5.94%）、南微医学（4.99%）、圣 湘生物（4.84%）、心脉医疗（4.35%）、海尔生物（3.92%）、亚辉龙（3.41%）。 从上证科创板医疗指数持仓样本的行业来看，医疗耗材占比42.66%、医疗设备占比30.80%、体外诊断 占比26.54%。 资料显示，指数样本每季度调整一次，样本调整实施时间分别为每年3月、6月、9月和12月的第二个星 期五的下一交易日。权重因子随样本定期调整而调整，调整时间与指数样本定期调整实施时间相同。在 下一个定期调 ...

Overview - The article discusses the share transfer of Yirui Technology Group Co., Ltd. (奕瑞科技) by its shareholder Hainan Heyi Investment Co., Ltd. (海南合毅) to specific institutional investors, organized by China International Capital Corporation (中金公司) [1] Group 1: Share Transfer Overview - The share transfer is being conducted through a price inquiry process as per relevant regulations [1] - The transfer involves a thorough qualification check of the selling shareholder, Hainan Heyi, by China International Capital Corporation [1] Group 2: Qualification Check Process - The qualification check was completed on June 4, 2025, including verification of business registration documents and ownership proof [2] - Hainan Heyi is registered in Hainan Province with a registered capital of 30 million RMB and has been operational since September 12, 2012 [3] - The company is engaged in investment activities and venture capital, with no legal or regulatory issues affecting its operational status [2][3] Group 3: Compliance with Regulations - The inquiry transfer does not violate any regulations regarding share reduction, as the annual and quarterly reports were announced prior to the transfer [4][5] - The transfer complies with the guidelines set forth by the China Securities Regulatory Commission and the Shanghai Stock Exchange [5][6] - China International Capital Corporation confirms that Hainan Heyi meets all necessary qualifications for participating in the share transfer [6]

Key Points - The core point of the announcement is the planned share transfer by Hainan He Yi Investment Co., Ltd. of 6,122,448 shares, representing 3.06% of Yirui Technology's total share capital, through a non-public inquiry transfer [1][2][4] Group 1: Share Transfer Details - The total number of shares to be transferred is 6,122,448, which accounts for 3.06% of Yirui Technology's total share capital [1][2] - The transfer will not be conducted through centralized bidding and the shares cannot be transferred by the acquirer within six months after the acquisition [1][2] - The acquirer must be an institutional investor with appropriate pricing capabilities and risk tolerance [1][3] Group 2: Seller Information - The seller, Hainan He Yi, is not a controlling shareholder or actual controller of Yirui Technology and does not hold more than 5% of the shares [1][2] - Hainan He Yi has confirmed that the shares are free from any transfer restrictions and comply with relevant regulations [1][2] Group 3: Pricing and Transfer Process - The minimum transfer price will be determined based on the guidelines from the Shanghai Stock Exchange and will not be lower than the date of sending the subscription invitation [2][3] - The pricing process will prioritize subscription price, followed by subscription quantity, and then the time of receipt of the subscription forms [3] Group 4: Company Status - Yirui Technology does not have any undisclosed operational risks or circumstances that could lead to a change in control due to this share transfer [4] - There are no other significant undisclosed matters related to the company [4]

中国国际金融股份有限公司 关于奕瑞电子科技集团股份有限公司 股东向特定机构投资者询价转让股份 相关资格的核查意见 中国国际金融股份有限公司(以下简称"中金公司")受奕瑞电子科技集团股 份有限公司(以下简称"奕瑞科技，，)股东海南合毅投资有限公司(以下简称 海南 合毅'或"出让方，，)委托，组织实施本次奕瑞科技股东向特定机构投资者询价转让 (以下简称"本次询价转让")。 根据《关于在上海证券交易所设立科创板并试点注册制的实施意见)) <<科创 板上市公司持续监管办法(试行))) <<上海证券交易所科创板股票上市规则》 《上海证券交易所科创板上市公司自律监管指引第 号一一询价转让和配售》 (以下简称" <<询价转让和配售指引)) ")等相关规定，中金公司对参与本次询价 出让方的相关资格进行了核查。 本次询价转让的委托情况、出让方相关资格的核查情况及核查意见如下: 一、本次询价转让概述 2024 11 日，中金公司收到出让方关于本次询价转让的委托，委托中金 公司组织实施本次询价转让。 二、关于参与本次询价转让股东相关资格的核查情况 (一)核查过程 根据相关法规要求，中金公司己于2025 日完成全部出让方相关资格的 ...

| 证券代码：688301 | 证券简称：奕瑞科技 | 公告编号：2025-043 | | --- | --- | --- | | 转债代码：118025 | 转债简称：奕瑞转债 | | 奕瑞电子科技集团股份有限公司 股东询价转让计划书 海南合毅投资有限公司保证向奕瑞电子科技集团股份有限公司提供的信息 内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准 确性和完整性依法承担法律责任。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： 拟参与奕瑞电子科技集团股份有限公司（以下简称"奕瑞科技"或"公司"） 首发前股东询价转让（以下简称"本次询价转让"）的股东为海南合毅投资有限公 司（以下简称"海南合毅"或"出让方"）。 出让方拟转让股份的总数为6,122,448股，占奕瑞科技股本比例为3.06%。 本次询价转让为非公开转让，不会通过集中竞价交易方式进行。受让方 通过询价转让受让的股份，在受让后6个月内不得转让。 本次询价转让的受让方为具备相应定价能力和风险承受能力的机构投资 者。 一、拟参与转让的股东情况 （一）出让方的名称、持股数量、持股比例 出让方委托中国 ...

股票代码：688301 股票简称：奕瑞科技 债券代码：118025 债券简称：奕瑞转债 奕瑞电子科技集团股份有限公司 向不特定对象发行可转换公司债券 第三次临时受托管理事务报告 （2025 年度） 债券受托管理人 二〇二五年六月 重要声明 本报告依据《公司债券发行与交易管理办法》《关于上海奕瑞光电子科技股 份有限公司向不特定对象发行可转换公司债券之债券受托管理协议》（以下简称 "《受托管理协议》"）《上海奕瑞光电子科技股份有限公司向不特定对象发行 可转换公司债券募集说明书》（以下简称"《募集说明书》"）等相关规定，由 本次债券受托管理人中国国际金融股份有限公司（以下简称"中金公司"）编制。 中金公司对本报告中所包含的从上述文件中引述内容和信息未进行独立验证，也 不就该等引述内容和信息的真实性、准确性和完整性做出任何保证或承担任何责 任。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关 事宜做出独立判断，而不应将本报告中的任何内容据以作为中金公司所作的承诺 或声明。在任何情况下，投资者依据本报告所进行的任何作为或不作为，中金公 司不承担任何责任。 1 中国国际金融股份有限公司作为奕瑞电子科技 ...